GNCP 3-4-19
The Current Board of Directors of GNCC Capital, Inc.* (“GNCC” or “the Company”), quoted on the OTC Markets under the Trading Symbol “GNCP” confirm that:
*The Current Directors depart the GNCC Board of Directors on or before March 31, 2019 (close of the Transition Period).
In the interests of greater transparency, GNCC’s Current Directors and the BioCann Pharma Group Management have today authorized their Transfer Agent to supply “live” information of our issued and outstanding shares of Common Stock. This will result in our Company having a “Transfer Agent Verified” logo on www.otcmarkets.com, indicating that the information is reliable and trustworthy. It is anticipated that this will be reflected within days given that our Transfer Agent is uploading the data today.
This provides our shareholders with true and accurate numbers of issued and outstanding shares of Common Stock, negating the need for shareholders to contact the Transfer Agent directly.
THE OTC MARKETS GROUP “Transfer Agent Verified Shares Program”
The Transfer Agent Verified Shares Program provides reliable share data to investors of OTCQX, OTCQB and Pink securities by allowing participating transfer agents to submit verified shares outstanding information on a regular basis for their clients directly to OTC Markets Group.
Effective January 1, 2019, U.S. OTCQX and OTCQB companies will be required to provide verified share data through a transfer agent who participates in the Transfer Agent Verified Shares Program. OTC Markets Group will also use this data to confirm compliance with OTCQX and OTCQB market rules.
Whilst GNCC is not quoted on either of the OTCQX nor OTCQB Markets, this was a voluntary decision taken by your Current Directors and by BioCann Pharma Management.
DATED: MARCH 4, 2019
RONALD YADIN LOWENTHAL GNCC CAPITAL, INC. EXECUTIVE CHAIRMAN
NICOLAAS EDWARD BLOM
GNCC CAPITAL, INC.
PRESIDENT & CHIEF OPERATING OFFICER
